Singapore, April 21 -- ACTmed, a joint venture between Canon Medical Systems Corporation and ACT Genomics, has established an analysis laboratory named "Shonan iPark Laboratory" in "Shonan Health Innovation Park". With the laboratory, ACTmed will offer precision cancer medicine to fulfill the clinical needs and drug development activities in Japan, making it possible to provide comprehensive services to quickly address requests from clients and promptly respond to their inquiries. Full-scale operation is scheduled to commence in July 2019.

ACT Genomics will continue to provide medical informatics solution through its AI-powered bioinformatics pipelines to ACTmed, which enable the joint venture to provide medical interpretation that is cr...